![James Groves](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
James Groves served as Director at Caristo Diagnostics Ltd.
from 2018 to 2022.
Prior to that, he worked as Principal Licensing & Ventures Manager at Oxford University Innovation Ltd.
Mr. Groves received his graduate degree from the University of Oxford in 2006 and his undergraduate degree from The University of Nottingham in 2005.
Anciens postes connus de James Groves
Sociétés | Poste | Fin |
---|---|---|
Caristo Diagnostics Ltd.
![]() Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2022 |
Oxford University Innovation Ltd.
![]() Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Private Equity Investor | - |
Formation de James Groves
University of Oxford | Graduate Degree |
The University of Nottingham | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Oxford University Innovation Ltd.
![]() Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom. | Finance |
Caristo Diagnostics Ltd.
![]() Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |